X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.


PreviousEntry : {C0F6924D-7ECC-4DF4-9B11-F3DE0C76AF75} | Display Title : Particles in Parenteral Drug Products - Measuring and Mitigating
NextEntry : {B30520C9-21E9-48D3-864D-8155EDA22ABE} | Display Title : Particles in Parenteral Drug Products - Measuring and Mitigating
Sources

1. Multistate Outbreak of Fungal Meningitis and Other Infections. US Centers for Disease Control and Prevention website. Updated 30 October 2015. Available at: https://www.cdc.gov/HAI/outbreaks/meningitis.html. Accessed 11 April 2019.

2. Food and Drug Administration. Current Good Manufacturing Practice—Guidance for Human Drug Compounding Outsourcing Facilities Under Section 503B of the FD&C Act (Guidance for Industry) December 2018; Available at: https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM403496.pdf. Accessed 11 April 2019.

Previous Next
Amy Kim

Amy Kim

Sr. Specialist, Scientific Communications, SA & TS

Subscribe to receive the latest blog post